Simon N. Pimstone, President & CEO at Xenon Pharmaceuticals Inc. (XENE), bought 6,000 shares at $2.90 ($17K) on 2017-08-10, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |